Identification of a ligand for the c-kit proto-oncogeneDouglas E. Williams, Stewart D. Lyman, June Eisenman et al.|Cell|1990Cited by 954
Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosingJacob Appelbaum, Michael C. Jensen, Dong Xia et al.|Journal of Clinical Investigation|2024Cited by 51
High Efficiency CRISPR/Cas9-mediated Gene Editing in Primary Human T-cells Using Mutant Adenoviral E4orf6/E1b55k “Helper” ProteinsKamila Gwiazda, Andrew M. Scharenberg, Alexandra E. Grier et al.|Molecular Therapy|2016Cited by 35